Popp, P.F.; Lozano-Cruz, T.; Dürr, F.; Londaitsbehere, A.; Hartig, J.; de la Mata, F.J.; Gómez, R.; Mascher, T.; Revilla-Guarinos, A.
The Novel Synthetic Antibiotic BDTL049 Based on a Dendritic System Induces Lipid Domain Formation while Escaping the Cell Envelope Stress Resistance Determinants. Pharmaceutics 2023, 15, 297.
https://doi.org/10.3390/pharmaceutics15010297
AMA Style
Popp PF, Lozano-Cruz T, Dürr F, Londaitsbehere A, Hartig J, de la Mata FJ, Gómez R, Mascher T, Revilla-Guarinos A.
The Novel Synthetic Antibiotic BDTL049 Based on a Dendritic System Induces Lipid Domain Formation while Escaping the Cell Envelope Stress Resistance Determinants. Pharmaceutics. 2023; 15(1):297.
https://doi.org/10.3390/pharmaceutics15010297
Chicago/Turabian Style
Popp, Philipp F., Tania Lozano-Cruz, Franziska Dürr, Addis Londaitsbehere, Johanna Hartig, Francisco Javier de la Mata, Rafael Gómez, Thorsten Mascher, and Ainhoa Revilla-Guarinos.
2023. "The Novel Synthetic Antibiotic BDTL049 Based on a Dendritic System Induces Lipid Domain Formation while Escaping the Cell Envelope Stress Resistance Determinants" Pharmaceutics 15, no. 1: 297.
https://doi.org/10.3390/pharmaceutics15010297
APA Style
Popp, P. F., Lozano-Cruz, T., Dürr, F., Londaitsbehere, A., Hartig, J., de la Mata, F. J., Gómez, R., Mascher, T., & Revilla-Guarinos, A.
(2023). The Novel Synthetic Antibiotic BDTL049 Based on a Dendritic System Induces Lipid Domain Formation while Escaping the Cell Envelope Stress Resistance Determinants. Pharmaceutics, 15(1), 297.
https://doi.org/10.3390/pharmaceutics15010297
